UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549
      ---------------------------------------------------------------------

                                   FORM 10-QSB

                QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d)
                     OF THE SECURITIES EXCHANGE ACT OF 1934

                For the quarterly period ended September 30, 2005

                          Commission File No. 333-94265

                              Liska Biometry, Inc.
      ---------------------------------------------------------------------
        (Exact Name of small business issuer as specified in its charter)

                 FLORIDA                              06-1562447
--------------------------------------  ----------------------------------------
     (State or other jurisdiction of      (IRS Employer Identification No.)
      incorporation or organization)

                            100 Main Street Suite 230
                           Dover, New Hampshire, 03820
     -----------------------------------------------------------------------
                    (Address of Principal Executive Offices)

                                 1 877 77 LISKA
          (Telephone number, including area code, of agent for service)

                                   Copies to:

                            Virginia K. Sourlis, Esq.
                                  The Galleria
                                 2 Bridge Avenue
                               Red Bank, NJ 07701
                            (732) 530-9007 Fax (732)
                           530-9008 www.SourlisLaw.com

Registrant has filed all reports  required to be filed by Section 13 or 15(d) of
the Securities  Exchange Act of 1934 during the preceding 12 months and has been
subject to such filing requirements for the past 90 days. |X| Yes |_| No

<PAGE>

                      APPLICABLE ONLY TO CORPORATE ISSUERS

As of  September  30,  2005,  we  had  26,291,263  shares  of our  common  stock
                                  outstanding.

                              LISKA BIOMETRY, INC.
                            INDEX TO QUARTERLY REPORT
                                 ON FORM 10-QSB
<TABLE>
<CAPTION>
                                                                                                                Page
PART I - FINANCIAL INFORMATION
<S>                                                                                                                <C>
           Item 1 - Financial Statements
                     Balance Sheet (Unaudited)                                                                     3
                     Statements of Operations (Unaudited)                                                          4
                     Statements of Cash Flows (Unaudited)                                                          5
                     Notes to Financial Statements                                                                 6
           Item 2 - Management's Discussion and Analysis or Plan of Operations                                     7
           Item 3 - Controls and Procedures                                                                       15
PART II - OTHER INFORMATION
           Item 6 - Exhibits and Reports on Form 8-K                                                              17
           Signatures                                                                                             18
</TABLE>

                                       2
<PAGE>

                              Liska Biometry, Inc.
                          (A Development Stage Company)
                           Consolidated Balance Sheet
                               September 30, 2005
                                   (Unaudited)

Assets

Current assets:
    Cash                                                            $    11,726

    Prepaid expenses                                                      1,042

    Miscellaneous receivables                                             6,836
                                                                    -----------
         Total Current Assets                                            19,604
                                                                    -----------

Fixed assets, net                                                        57,657
                                                                    -----------

Other assets:
   Deposits                                                              21,502
                                                                    -----------

                                                                    $    98,763
                                                                    ===========

Liabilities and stockholders' (deficit)

Current liabilities:
   Accounts payable & accrued expenses                              $   360,306
   Due to investors                                                      55,000
                                                                    -----------
          Total current liabilities                                     415,306
                                                                    -----------

Stockholders' (deficit):
   Preferred stock, no par value,

      10,000,000 shares authorized, none outstanding                         --
   Common stock, no par value,
      100,000,000 shares authorized,
       26,291,263 shares issued and outstanding                       8,641,550
   Common stock subscriptions                                            20,000
   Additional paid in capital                                           933,203
   Deferred compensation                                                (25,250)
  (Deficit) accumulated during the development stage                 (9,868,678)
                                                                    -----------
                                                                       (299,175)
  Other comprehensive income:
    Currency translation adjustment                                     (17,368)
                                                                    -----------
                                                                       (316,543)
                                                                    -----------

                                                                    $    98,763
                                                                    ===========

See the accompanying notes to the consolidated financial statements.

                                       3
<PAGE>

                              Liska Biometry, Inc.
                          (A Development Stage Company)
                      Consolidated Statements of Operations
                 Three Months Ended September 30, 2004 and 2005,
                         Nine Months Ended September 30,
                          2004 and 2005, and Inception
                          (August 1, 2000) to September
                                    30, 2005
                                   (Unaudited)
<TABLE>
<CAPTION>

                                                                          Three Months          Three Months         Nine Months
                                                                              Ended                Ended                Ended
                                                                          September 30,        September 30,        September 30,
                                                                              2004                  2005                 2004
                                                                        ------------------    -----------------    -----------------

<S>                                                                      <C>                  <C>                 <C>
Sales                                                                    $              -     $              -    $               -

Cost of goods sold                                                                      -                    -                    -
                                                                        ------------------    -----------------    -----------------

Gross profit                                                                            -                    -                    -
                                                                        ------------------    -----------------    -----------------

Operating expenses:

   Impairment of license                                                                -                    -                    -
   Selling, general and
administrative expenses -

      Non cash stock compensation                                                 642,542               59,083            3,482,542
   Selling, general and
administrative expenses                                                            69,126              473,669              286,465
                                                                        ------------------    -----------------    -----------------


                                                                                  711,668              532,752            3,769,007
                                                                        ------------------    -----------------    -----------------

(Loss) from operations                                                          (711,668)            (532,752)           (3,769,007)
                                                                        ------------------    -----------------    -----------------

Other income (expense):

   Other income                                                                         -                    -                    -
                                                                        ------------------    -----------------    -----------------

Net (loss)                                                                      (711,668)            (532,752)           (3,769,007)

Other comprehensive income:
  Foreign currency translation
adjustment                                                                        (2,453)              (9,769)                  600
                                                                        ------------------    -----------------    -----------------

Comprehensive (loss)                                                     $      (714,121)     $      (542,521)     $    (3,768,407)
                                                                        ==================    =================    =================

Per share information - basic and fully diluted:

  Weighted average shares outstanding                                         21,009,578           26,058,726            18,767,692
                                                                        ==================    =================    =================
  Net (loss) per share
                                                                        $          (0.03)     $          (0.02)    $          (0.20)
                                                                        ==================    =================    =================
</TABLE>


                                           Nine Months     Inception
                                              Ended           to
                                          September 30,   September 30,
                                              2005           2005
                                                   --             --

 Sales                                   $         --   $      8,000

 Cost of goods sold                                --            892
                                         ------------   ------------

 Gross profit                                      --          7,108
                                                   --             --

 Operating expenses:

    Impairment of license                          --         58,812
    Selling, general and
 administrative expenses -

       Non cash stock compensation            815,545      4,511,478
    Selling, general and
 administrative expenses                    1,053,740      5,305,746

                                         ------------   ------------

                                            1,869,285      9,876,036
                                         ------------   ------------

 (Loss) from operations                    (1,869,285)    (9,868,928)
                                                   --             --

 Other income (expense):

    Other income                                   --            250
                                                   --             --

 Net (loss)                                (1,869,285)    (9,868,678)

 Other comprehensive income:
   Foreign currency translation
 adjustment                                   (16,037)       (17,368)
                                         ------------   ------------

 Comprehensive (loss)                    $ (1,885,322)    (9,886,046)
                                         =============  ==============

 Per share information - basic and fully

   Weighted average shares outstanding     25,376,716
                                         ============
   Net (loss) per share

                                         $      (0.07)
                                         ============

See the accompanying notes to the consolidated financial statements.


                                       4
<PAGE>


                              Liska Biometry, Inc.
                          (A Development Stage Company)
                      Consolidated Statements of Cash Flows
               Nine Months Ended September 30, 2004 and 2005, and
                Inception (August 1, 2000) to September 30, 2005
                                   (Unaudited)
<TABLE>
<CAPTION>


                                                                       Nine Months            Nine Months         Inception to
                                                                    Ended September30,     Ended September 30,    September 30,
                                                                          2004                     2005               2005
                                                                       -----------             -----------         -----------
Cash flows from operating activities:
<S>                                                                    <C>                     <C>                 <C>
Net cash (used in) operating activities                                $  (283,117)            $  (836,541)        $(1,631,997)
                                                                       -----------             -----------         -----------

Cash flows from investing activities:

Net cash (used in) investing activities                                    (11,300)                (44,322)           (118,857)
                                                                       -----------             -----------         -----------

Cash flows from financing activities:

  Capital contributions                                                         --                      --               8,878

  Common shares issued and subscriptions for cash                          356,912                 674,500           1,898,702

  Common shares repurchased for cash                                       (50,000)                     --            (200,000)

  Net proceeds (payments) from (on) investor loans                          49,827                 (27,552)             55,000
                                                                       -----------             -----------         -----------

Net cash provided by financing activities                                  356,739                 646,948           1,762,580
                                                                       -----------             -----------         -----------

Net increase (decrease) in cash                                             62,322                (233,915)             11,726

Beginning - cash balance                                                       843                 245,641                  --
                                                                       -----------             -----------         -----------

Ending - cash balance                                                  $    63,165             $    11,726         $    11,726
                                                                       ===========             ===========         ===========

Supplemental cash flow information:
  Cash paid for income taxes                                           $        --             $        --         $        --
                                                                       ===========             ===========         ===========
  Cash paid for interest                                               $        --             $        --         $        --
                                                                       ===========             ===========         ===========
</TABLE>

                                       5
<PAGE>

                              LISKA BIOMETRY, INC.
                          (A DEVELOPMENT STAGE COMPANY)
                   NOTES TO CONSOLIDATED FINANCIAL STATEMENTS
                               SEPTEMBER 30, 2005
                                   (UNAUDITED)

(1)   Basis Of Presentation

The accompanying  unaudited consolidated financial statements have been prepared
in accordance with generally accepted  accounting  principles (GAAP) for interim
financial information and Item 310(b) of Regulation S-B. They do not include all
of the  information  and  footnotes  required  by GAAP  for  complete  financial
statements.  In the opinion of management,  all adjustments  (consisting only of
normal recurring adjustments)  considered necessary for a fair presentation have
been included.

The  results  of  operations  for the  periods  presented  are  not  necessarily
indicative  of the  results  to be  expected  for the  full  year.  For  further
information, refer to the financial statements of the Company as of December 31,
2004, and for the two years then ended, and the period from inception (August 1,
2000) to December 31, 2004,  including  notes thereto  included in the Company's
Form 10-KSB.

(2)   Earnings Per Share

The Company  calculates  net income (loss) per share as required by Statement of
Financial  Accounting Standards (SFAS) 128, "Earnings per Share." Basic earnings
(loss) per share is  calculated  by dividing  net income  (loss) by the weighted
average number of common shares  outstanding  for the period.  Diluted  earnings
(loss) per share is  calculated  by dividing  net income  (loss) by the weighted
average  number  of  common  shares  and  dilutive   common  stock   equivalents
outstanding.  During  periods  when they  would be  anti-dilutive  common  stock
equivalents, if any, are not considered in the computation.

(3)   Commitments and Contingencies

During the periods  covered by these  financial  statements  the Company  issued
shares of common stock without  registration  under the  Securities Act of 1933.
Although the Company  believes that the sales did not involve a public  offering
of its  securities  and that the  Company  did  comply  with the  "safe  harbor"
exemptions from registration,  it could be liable for rescission of the sales if
such exemptions were found not to apply and this could have a material  negative
impact on the  Company's  financial  position  and  results  of  operations.  In
addition,  the  Company  issued  shares of  common  stock  pursuant  to Form S-8
registration  statements.  The  Company  believes  that  it  complied  with  the
requirements  of Form S-8 in  regard  to  these  issuances,  however  if it were
determined  that there were violations of the provisions of Form S-8 the Company
could be subject to enforcement proceedings.

During the periods  covered by these  financial  statements the Company  entered
into several  employment,  consulting and other  agreements  with third parties.
Although  the  Company  obtained  settlement  releases  from a  majority  of the
parties, settlement releases were not entered into with some of these parties or
the settlement  releases were verbal  agreements.  Future  contingencies,  which
cannot be estimated by management, may exist for the above matters including but
not limited to issuance of capital stock and other financial obligations and may
have a material negative impact on the Company's  financial position and results
of operations.

At  September  30,  2005,  the  Company  and its  subsidiary  had  entered  into
employment  contracts  of varying  terms  ending  from  September  2005  through
November 2006 with six officers and senior  executives  for annual  compensation
aggregating  approximately  $385,000.  In addition  these  officers  received an
aggregate  of  2,255,000  shares of  common  stock  (see  Note 4).  One of these
officers has also received  options to purchase a total of 400,000 common shares
as a result of reaching  certain  performance  targets  during the contract term
that ended September 2005. This contract was subsequently renewed.

                                       6
<PAGE>

At  September  30, 2005 the Company had entered  into  consulting  contracts  of
varying terms ending from May through  November 2006 with various  employees and
consultants  for varying fees  depending  upon services  rendered.  One of these
employment  contracts  provide that the  consultants may also receive options to
purchase  a total of 250,000  common  shares  depending  upon  reaching  certain
performance targets during the contract term that ends November 2005.

(4)   Stockholders' (Deficit)

During the nine months  ended  September  30, 2005 the  Company  issued  621,346
shares of common stock which had been subscribed for at December 31, 2004.

During the nine months ended  September 30, 2005, the Company  issued  1,991,162
shares of  common  stock  for  services  including  services  rendered  or to be
rendered pursuant to employment and consulting contracts. The shares were valued
at their fair market  value of $773,378,  of which  $748,128 has been charged to
operations  and $25,250 has been  recorded as deferred  compensation  related to
services not yet provided. In addition,  $67,417 previously recorded as deferred
compensation  at December 31, 2004,  has been  amortized to operations  over the
term of certain consulting and employment contracts.

During the nine months  ended  September  30, 2005,  the Company  also  accepted
subscriptions  for 2,016,254  shares of common stock at prices ranging from $.20
to $.38, for cash aggregating $674,500 of which 75,000 shares ($20,000) have not
been issued at  September  30,  2005,  and have been  recorded  as common  stock
subscriptions.

During July 2005, the Company cancelled 1,871,666 treasury shares.

During the nine months ended September 30, 2005, the Company issued an aggregate
of  975,000  options  to  employees  exercisable  for a period  of ten  years at
exercise prices ranging $.32 to $.61.

SFAS 123  requires the Company to provide  proforma  information  regarding  net
income and earnings per share as if  compensation  cost for the Company's  stock
option plans had been  determined in accordance with the fair value based method
prescribed  in SFAS 123. The fair value of the option grants is estimated on the
date of  grant  utilizing  the  Black-Scholes  option  pricing  model  with  the
following  weighted  average  assumptions  for grants  during  the period  ended
September 30, 2005: expected life of options of 10 years, expected volatility of
99% to 208%,  risk-free  interest rate of 3% and no dividend yield. The weighted
average  fair  value at the date of grant for  options  granted  during the nine
months ended September 30, 2005,  approximated  $0.36 per option.  These results
may not be representative of those to be expected in future years.

Under the  provisions  of SFAS 123, the Company's net income (loss) and earnings
(loss) per share would have been reduced  (increased)  to the pro forma  amounts
indicated below for the period ended September 30, 2005:

Net (loss)
           As reported                                        $(1,869,285)
            Pro forma                                         $(2,054,285)
Basic and diluted (loss) per share
            As reported                     $(.07)
            Pro forma                       $(.08)

                                       7
<PAGE>

A summary of stock option activity is as follows:
<TABLE>
<CAPTION>

                                                                   Weighted                 Weighted
                                                Number              average                 average
                                                  of               exercise                  fair
                                                shares                price                  value
                                                ------               ------                  -----

         Balance at

<S>                                           <C>                   <C>                     <C>
           December 31, 2004                   350,000               $.64                    $1.00
         Granted   2005                        975,000               $.38                   $  .36
         Exercised/Forfeited                       --
                                      ---------------
         Balance at
           September 30, 2005               1,325,000
                                            =========
</TABLE>

The following table summarizes information about fixed-price stock options at
September 30, 2005:
<TABLE>
<CAPTION>

                                            Outstanding
                             Weighted         Weighted         Weighted-
                              Average          Average          Average                Exercisable
         Exercise             Number         Contractual       Exercise            Number      Exercise
           Prices          Outstanding          Life            Price           Exercisable      Price
           ------          -----------          ----            -----           -----------      -----

<S>      <C>                    <C>         <C>                 <C>                <C>          <C>
         $.32                   295,000     10 years            $.32                      -      $  .32
         $.39                   650,000     10 years            $.39                      -      $  .39
         $.61                    30,000     10 years            $.61                      -      $  .61
         $.64 to $.65           350,000      9 years            $.64                350,000      $ 1.00
</TABLE>

(5)   Basis of Reporting

The Company's financial statements are presented on a going concern basis, which
contemplates  the  realization of assets and  satisfaction of liabilities in the
normal course of business.

The Company has  experienced a significant  loss from  operations as a result of
its investment  necessary to achieve its operating plan,  which is long-range in
nature.  For the nine  months  ended  September  30,  2005,  and the period from
inception to September 30, 2005,  the Company  incurred net losses of $1,869,285
and $9,868,678  respectively and has working capital and stockholder deficits of
$395,701  and $316,543  respectively  at September  30, 2005.  In addition,  the
Company has no revenue generating operations.

The  Company's  ability to continue as a going  concern is  contingent  upon its
ability to attain profitable operations and secure financing.  In addition,  the
Company's  ability to continue as a going concern must be considered in light of
the problems, expenses and complications frequently encountered by entrance into
established  markets  and the  competitive  environment  in  which  the  Company
operates.

The Company is pursuing equity  financing for its operations.  Failure to secure
such financing or to raise  additional  capital or borrow  additional  funds may
result in the Company  depleting its available  funds and not being able pay its
obligations.

                                       8
<PAGE>

The financial  statements do not include any adjustments to reflect the possible
future effects on the recoverability and classification of assets or the amounts
and classification of liabilities that may result from the possible inability of
the Company to continue as a going concern.

(6)   Subsequent Events

During  October and November  2005,  the Company issued 725,000 shares of common
stock for cash aggregating  $181,250.  In addition the shares  subscribed for at
September 30, 2005, were issued.

During October 2005, the Company signed a securities  purchase agreement for the
issuance of 5 million shares of common stock at $0.275.  To date the shares have
been issued, but the cash proceeds have not been received.

Item 2     Management's Discussion and Analysis or Plan of Operation

CAUTIONARY NOTE REGARDING FORWARD-LOOKING STATEMENTS

This report contains "forward-looking"  statements within the meaning of Section
27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act
of 1934 and is subject to the safe harbor created by those  sections.  We intend
to  identify  forward-looking  statements  in this report by using words such as
"believes,"  "intends," "expects," "may," "will," "should," "plan," "projected,"
"contemplates," "anticipates," "estimates," "predicts," "potential," "continue,"
or similar  terminology.  These statements are based on the Company's beliefs as
well as assumptions the Company made using  information  currently  available to
us. The  Company  undertakes  no  obligation  to  publicly  update or revise any
forward-looking  statements,  whether  as a result  of new  information,  future
events,  or otherwise.  Because these statements  reflect the Company's  current
views concerning future events,  these statements involve risks,  uncertainties,
and assumptions. Actual future results may differ significantly from the results
discussed in the  forward-looking  statements.  These risks  include  changes in
demand for the Company's  products,  changes in the level of operating expenses,
changes in  general  economic  conditions  that  impact  consumer  behavior  and
spending, product supply, the availability,  amount, and cost of capital for the
Company and the Company's use of such capital, and other risks discussed in this
report.  Additional  risks that may affect our  performance  are discussed under
"Risk  Factors  Associated  with Our Business" in our Form 10-KSB for the fiscal
year ended December 31, 2004.  Readers are cautioned not to place undue reliance
on the  forward-looking  statements  contained in this  report.  We disclaim any
obligation to update forward-looking  statements. All references to "we", "our",
"us",  of  refer  to  Liska  Biometry,  Inc.,  and  it  predecessors,  operating
divisions, and subsidiaries.

CRITICAL ACCOUNTING POLICIES

There were no changes to the Company's critical accounting policies in the third
quarter  of  2005.  Critical  accounting  policies  are  those  applications  of
accounting   principles  or  practices  that  require   considerable   judgment,
estimation, or sensitivity analysis by management.

                                       9
<PAGE>

PLAN OF OPERATIONS

We plan to complete  our current Plan of  Operations  over a period of six to 12
months. At the present time we do not have sufficient cash resources to complete
our Plan of Operations. We have not had sufficient cash resources to conduct our
Plan of  Operations  since  we  adopted  our  new  business  plan of  developing
fingerprint   encoding   and   authentication   technology.    Therefore,   full
implementation  of our Plan of Operations is contingent upon receiving  adequate
financing to meet the remaining costs of our estimate of $4,500,000

Our Plan of Operations (on a consolidated basis) to Date:

RESEARCH AND DEVELOPMENT

In January 2003 we developed a preliminary  demonstration  model of our proposed
fingerprint  technology,  which  provided  only a  conceptual  guide for  future
development.  We continued  our  development  throughout  2003 and  attempted to
improve our core technology and implement changes in our core software; however,
most of our  development  occurred from September 2004 to June 2005, in which we
made further  changes to our core  software.  As reflected  below in our Plan of
Operations,  we will continue to develop our core  technology  incrementally  as
financing becomes available.

DEVELOPED SOFTWARE ALGORITHMS

Using third party  live-scan  fingerprint  scanners,  we can now demonstrate the
proof  of  concept  of  our  proprietary  software  concepts,  illustrating  the
differentiating  features  of  embedded  software  algorithms  -  that  is,  the
capability to measure the stable  content of a fingerprint  image and to express
it as a short numeric  output.  A final workable  prototype  model is contingent
upon us receiving financing,  which we may be unable to obtain. We have expended
approximately $6,000 for the aforementioned.

APPOINTED EXECUTIVE MANAGEMENT TEAM

We have filled the following executive  management positions to our consolidated
operation:

               Position                 Annual Salary (Consolidated Basis)

           Chief Executive                           $90,000

Chief Financial Officer and President                $85,000
          of Liska Biometry
            (Canada) Inc.

We estimate  that our annual salary  expenditures  for these  positions  will be
$175,000.

CAPITAL EXPENDITURES

We have purchased capital equipment for our research and development and general
operations,  which  consists  primarily  of computer  hardware.  We estimate the
remaining cost of our needed equipment to be approximately $40,000.

HIRED VICE PRESIDENT OF PRODUCT OPERATIONS

We have hired one  individual  who is  responsible  for the  product  operations
oversight of the Company.  The annual salary costs associated with this position
is approximately $80,000.

                                       10
<PAGE>

HIRED A CHIEF SOFTWARE ARCHITECT

We have hired an  individual  who is  responsible  for leading the  research and
development of the Company's intellectual property and core software algorithms

The annual salary costs associated with this position is approximately $70,000.

HIRED A CHIEF ENGINEER

We have hired an individual who is responsible for  implementing  the technology
integration and designing the Company's product applications.

The annual salary costs associated with this position is approximately $70,000.

HIRED A HUMAN RESOURCE MANAGER

We   have   hired   one   individual   who  is   responsible   for   all   human
resource/administrative functions of the Company.

The annual salary costs associated with this position is approximately $60,000.

HIRED A FINANCIAL CONTROLLER/ SENIOR FINANCIAL ADVISOR

We have hired one  individual on a part-time  basis who is  responsible  for the
financial  accounting,  audit procedures and the internal  financial controls as
well as advising the executive  management  on the  financial  management of the
Company.

The annual salary costs associated with this position is approximately $60,000.

HIRED AN RESEARCH & DEVELOPMENT TEAM

We have hired individuals to fill the following positions:

      o     Senior Technical Support Engineer
      o     Senior Security Systems Engineer
      o     Network Communication and Security Development Engineer
      o     Senior Software Programmer
      o     One part-time programmer

Several  of these  individuals  have  been  reallocated  to  roles  in  business
development, The estimated annual salary cost associated with those remaining is
$220,000.

HIRED A SENIOR VICE-PRESIDENT OF OPERATIONS AND DIRECTOR OF BUSINESS DEVELOPMENT

We hired an individual who is responsible for  implementing  the US-based sales,
marketing,  and business development initiatives of the Company and implementing
operational  strategies  in concert  with the CEO and CFO of the  Company.  This
individual  oversees the operational  implementation  of the Company's  business
plan and manages its US-based operational units.

The estimated annual salary costs associated with this position is approximately
$70,000.

                                       11
<PAGE>

HIRED A VICE-PRESIDENT OF REGIONAL SALES FOR THE MIDDLE EAST

We hired an individual who is responsible  for  implementing  the Middle Eastern
based sales and business development initiatives of the Company.

The estimated annual salary costs associated with this position is approximately
$60,000.

HIRED A VICE-PRESIDENT OF SALES & MARKETING

We hired an individual who is responsible  for  implementing  the Canadian based
sales, marketing, and business development initiatives of the Company.

The estimated annual salary costs associated with this position is approximately
$65,000.

HIRED AN ADMINISTRATOR & BOOK KEEPER

We hired an individual to be responsible for all of the administrative functions
at the Company's head office in Dover, New Hampshire.

The estimated annual salary costs associated with this position is approximately
$40,000.

HIRED A VICE PRESIDENT OF GLOBAL SOLUTIONS

We hired an individual who will be responsible  for  implementing  the Company's
customized solutions segment marketing and business development strategy.

The estimated annual salary costs associated with this position is approximately
$80,000.

Our Future Plan of Operations:

HIRE A CHIEF TECHNOLOGY OFFICER

We plan to hire an individual who will be responsible  for overseeing all of the
Company's R&D functions at its facilities in Ottawa, Canada.

The estimated annual salary costs associated with this position is approximately
$70,000.

HIRE A PRODUCT DEVELOPMENT/INTEGRATION TEAM

We  plan  to  hire a team  individuals  who  will  be  responsible  for  product
development,   quality  assurance  and  testing,   project   implementation  and
programming.

The estimated  annual salary costs  associated  with this team is  approximately
$975,000.

                                       12
<PAGE>

GENERAL & ADMINISTRATIVE EXPENSES

We intend to expend  funds for  general  and  administrative  expenses  such as:
insurance expense, payroll tax, rent expense, legal expenses, professional fees,
telephony  and  internet  access,  travel  &  entertainment,  payroll  expenses,
professional fees and offices expenses.

The remaining  estimated  annual costs  associated  with these  expenditures  is
approximately $978,000

ENGAGE BUSINESS DEVELOPMENT CONSULTANTS

As  part  of  our  overall  marketing  strategy,  we  intend  to  hire  business
development consultants who are able to advance our marketing plan and establish
material business relationships for our marketing personnel.

The estimated annual costs  associated with these  expenditures is approximately
$75,000

DEVELOP AND INITIATE MARKETING EFFORT

Our marketing  personnel have conducted a preliminary  market  analysis and have
developed a market segmentation strategy that allows for product diversification
and expansion while remaining close to our core technological expertise.

      o     Horizontal Segmentation:  the Company intends to promote wide-spread
            acceptance  of the BIN(TM)  concept  for large  scale ID  management
            projects via a software product offering and IP licensing model. The
            focus is on large government and enterprise security contracts, both
            in North America and abroad.

      o     Vertical  Segmentation:  the Company  intends to build its  industry
            credibility by providing  customized niche applications for specific
            BIN(TM)  related  applications  in  direct  response  to  customer's
            requests.  These applications will be  domain/industry  specific and
            will entail a large service  component.  The focus is on small, high
            probability  pilot  and  private  enterprise  contracts  for  access
            control,  fleet management  security and transaction  authentication
            for financial institutions.

We will continue to develop  strategic  partner  alliances to collaborate on our
marketing and technological  integration  efforts.  Such strategic  partners may
include the following:

      o     Fingerprint biometrics hardware system vendors;

      o     Systems Integrators, defense contractors

      o     Original Equipment Manufacturers (OEMs), Channel Partners

      o     Other  distribution  channels  that target  military and  commercial
            security markets.

We intend to intensify our foreign sales and marketing efforts in Europe, Canada
and the Middle  East  where we have  received a  significant  reception  for our
customized solutions offerings.

In addition,  we will acquire other market  information  and contacts by joining
key  industry  groups and  hiring  industry  analysts,  attending  trade  shows,
traveling to meet potential clients/partners and designing print media/web based
promotional strategies.

The annual cost associated with this marketing effort is approximately $950,000.

                                       13
<PAGE>

EXPAND OUR PRODUCT APPLICATIONS INITIATIVES AND RESEARCH AND DEVELOPMENT

We will continue to develop our initial proprietary  software  algorithms,  with
several  iterations  planned  for 2005.  Our goal in this regard is to reach the
proof of concept stage,  illustrating the differentiating  features of these new
embedded  software  algorithms,  focusing  on  real-time  fingerprint  biometric
database search. The remaining annual cost associated with expanding the product
application and R&D functions is approximately $360,000.

SUMMARY OF ESTIMATED COSTS

--------------------------------------------------------------------------
Executive Management                           $                  175,000
--------------------------------------------------------------------------
Capital Expenditures                                               40,000
--------------------------------------------------------------------------
VP Product Operations                                              80,000
--------------------------------------------------------------------------
Chief Software Architect                                            70000
--------------------------------------------------------------------------
Chief Engineer                                                     70,000
--------------------------------------------------------------------------
Human Resource Manager                                             60,000
--------------------------------------------------------------------------
Financial Controller/Senior Financial Advisor                      60,000
--------------------------------------------------------------------------
Engineering Team                                                  220,000
--------------------------------------------------------------------------
Director of Business Development                                   70,000
--------------------------------------------------------------------------
VP Regional Sales                                                  60,000
--------------------------------------------------------------------------
VP Sales & Marketing - Canada                                      65,000
--------------------------------------------------------------------------
Executive Assistant/Bookkeeper                                     40,000
--------------------------------------------------------------------------
VP Global Solutions                                                80,000
--------------------------------------------------------------------------

Product Development/Integration Team                              975,000
--------------------------------------------------------------------------
Business Consultants                                               75,000
--------------------------------------------------------------------------
Initiate Marketing Effort                                         950,000
--------------------------------------------------------------------------
Chief Technology Officer                                           80,000
--------------------------------------------------------------------------
General & Administrative                                          978,000
--------------------------------------------------------------------------
Expand Product Application Initiatives                            360,000
--------------------------------------------------------------------------


TOTAL                                          $                4,508,000
--------------------------------------------------------------------------


REVENUES

We cannot  determine  whether our  revenues,  if any, will ever be sufficient to
produce a positive  cash flow or result in net  profits.  You  should  carefully
consider the discussion appearing below under "Liquidity and Capital Resources".
We earned no revenues  during Fiscal Year 2004 or to date in Fiscal Year 2005 or
in  connection  with our business plan of  developing  fingerprint  encoding and
authentication  technology.  We do not  expect  to  earn  significant  operating
revenues  in the  foreseeable  future.  Our losses  are  expected  to  continue,
principally  as a  result  of  our  estimated  expenditures  of  $4,500,000,  as
reflected above.

                                       14
<PAGE>

LIQUIDITY AND CAPITAL RESOURCES

As of September 30, 2005, we had limited cash  resources of only $11,726.  We do
not have any other internal sources of working  capital.  We did not receive any
revenues  during our Fiscal Year 2004 or to date in Fiscal Year 2005.  We do not
anticipate  earning  revenues  until  such  time  that we  obtain  financing  to
implement  our Plan of  Operations,  if ever.  Even if we  complete  our Plan of
Operations,  there  are no  assurances  that  we  will  successfully  develop  a
marketable product.

During  Fiscal Year 2004 and date in Fiscal Year 2005,  our  operating  expenses
have  exceeded our  revenues,  which has been $0. We have  insufficient  working
capital to fund our planned growth and ongoing operating expenses.  As a result,
we expect to continue to experience significant negative operating cash flow for
the foreseeable  future.  Our existing working capital will not be sufficient to
fund the continued  implementation  of our Plan of Operations during the next 12
months and to meet our general operating expenses.  If we do not have sufficient
working  capital  to  implement  our  Plan of  Operations,  we may have to cease
operations.

We have no alternative  Plan of Operations.  In the event that we do not receive
financing,  if our financing is inadequate or if we do not adequately  implement
an alternative Plan of Operations that enables us to conduct  operations without
having received  adequate  financing,  we may have to liquidate our business and
undertake any or all of the following actions:

      o     Sell or dispose of our assets, if any;

      o     Pay our liabilities in order of priority,  if we have available cash
            to pay such liabilities;

      o     If any cash remains after we satisfy  amounts due to our  creditors,
            distribute any remaining cash to our shareholders in an amount equal
            to the net market value of our net assets;

      o     File a Certificate of Dissolution with the State of Florida dissolve
            our corporation and close our business; and

      o     Make the  appropriate  filings  with  the  Securities  and  Exchange
            Commission  so that we will no longer be required  to file  periodic
            and  other  required   reports  with  the  Securities  and  Exchange
            Commission, if, in fact, we are a reporting company at that time

Based  upon our  current  assets,  however,  we will not  have  the  ability  to
distribute any cash to our shareholders.

If we have any  liabilities  that we are  unable to satisfy  and we qualify  for
protection  under  the  U.S.  Bankruptcy  Code,  we  may  voluntarily  file  for
reorganization  under Chapter 11 or  liquidation  under Chapter 7. Our creditors
may also file a Chapter 7 or Chapter 11  bankruptcy  action  against  us. If our
creditors or we file for Chapter 7 or Chapter 11 bankruptcy,  our creditors will
take priority over our  shareholders.  If we fail to file for  bankruptcy  under
Chapter 7 or Chapter 11 and we have  creditors,  such  creditors  may  institute
proceedings against us seeking forfeiture of our assets, if any.

We do not know and cannot  determine  which, if any, of these actions we will be
forced to take.

If any of these foregoing events occur, you could lose your entire investment in
our shares.

There is  substantial  doubt about our ability to continue as a going concern as
we have suffered recurring losses from operations and have no established source
of revenue.  Accordingly,  our  independent  auditors  included  an  explanatory
paragraph  in  their  report  on our  December  31,  2004  financial  statements
regarding  concerns  about our  ability  to  continue  as a going  concern.  Our
financial   statements  contain  additional  note  disclosures   describing  the
circumstances that lead to this disclosure by our independent auditors.

                                       15
<PAGE>

Item 3     Controls and Procedures

We maintain and are currently undertaking actions to improve disclosure controls
and procedures  designed to ensure that information  required to be disclosed in
reports  filed  under  the  Securities  Exchange  Act of 1934,  as  amended,  is
recorded, processed,  summarized and reported within the specified time periods.
As of the end of the period  covered by this  report,  the  Corporation's  Chief
Executive  Officer and Chief  Financial  Officer  ("CEO and CFO")  evaluated the
effectiveness of the Corporation's disclosure controls and procedures.  Based on
the evaluation, our CEO and CFO have discovered a potential material weakness in
our disclosure controls as they relate to the documents  supporting the issuance
of equity securities. Our CEO and CFO believe that the weaknesses did not affect
the reporting or  disclosure in our annual or quarterly  reports due to controls
put in place during the current quarter and compensating  controls,  such as the
detailed  review of these areas  subsequent to the time at which the  agreements
were  entered  into and  during  the  preparation  of our  quarterly  and annual
reports.

      These  weaknesses are currently  being addressed and actions are currently
being taken to improve our disclosure  controls and procedures;  and our CEO and
CFO have concluded that our disclosure  controls and  procedures,  combined with
compensating  controls are effective as of the end of the period covered by this
report in that  information  required  to be  disclosed  in this  10QSB has been
recorded, processed,  summarized and reported properly within the current fiscal
year.  Although  there was a change in our  disclosure  controls and  procedures
during the quarter, there were no changes in our internal control over financial
reporting  that  occurred  during our most  recent  nine month  period that have
materially affected, or are reasonably likely to materially affect, our internal
control over financial reporting.

      The  following is a summary of the weakness and  deficiency  that has been
identified and addressed:

      o     Deficiency  related to the  documentation,  review and  approval  of
            certain  sales  under  a  Regulation  S sale  of  securities  by our
            authorized broker/dealer agents.

      At our most  recent  year-end,  we  identified  a  deficiency  in controls
      related to documentation, review and approval of sales made under a series
      of Regulation S transactions.  Such deficiencies resulted in our inability
      to obtain supporting  documentation confirming the investor's intention to
      subscribe  to the shares sold despite  having  received the funds from the
      broker/agent  and despite having the  certificates  issued by our transfer
      agent. This deficiency did not exist for the private  placements  affected
      during the year.

As a result of the findings  above,  we have  implemented  and will  continue to
implement the following actions:

      o     We have  appointed a part-time  financial  controller to support the
            preparation of financial statements and reports to be filed with the
            SEC.

      o     We are establishing  procedures to improve our review and processing
            of non-accounting documentation and contracts, and specifically will
            require  adequate  documentation be provided  concurrently  with any
            future share subscriptions, regardless of type.

      o     We  intend  to  periodically  review  our  internal  procedures  and
            controls to ensure additional  enhancements to our internal controls
            are installed as necessary to meet our  operational  needs.  Outside
            consultants  will be engaged to advise  our  management  as areas of
            concern are identified.

      o     We intend to establish a Code of Ethics.

      Our management is committed to a sound internal  control  environment.  We
believe we have committed adequate  resources to the aforementioned  reviews and
remedies.  We believe that we have addressed the issue identified  above, and we
believe  that we are in the  process of further  improving  our  infrastructure,
personnel,  processes  and  controls  to help ensure that we are able to produce
accurate  disclosures  and  financial  statements  with  appropriate  supporting
documentation on a timely basis.

                                       16
<PAGE>

                            PART II OTHER INFORMATION

Item 2     Changes in Securities

During the quarter ending  September 30, 2005, the Company issued 125,000 shares
for services rendered.

The Company  sold the  following  unregistered  securities  following  the three
months ended September 30, 2005:

The  issuance  of these  securities  is claimed to be exempt  from  registration
pursuant  to  Section  4(2) of the  Securities  Act of  1933,  as  amended,  and
Regulation S as transactions by an issuer not involving a public offering.
<TABLE>
<CAPTION>

Date of Issuance             Description of Securities Issued    Number of Shares Issued       Purchase Price


<S>     <C>                         <C>                               <C>                          <C>
        27/07/2005                  Common Shares                     100,000                      $38,000
        27/07/2005                  Common Shares                     150,000                      $57,000
        27/07/2005                  Common Shares                     50,000                       $15,500
        08/08/2005                  Common Shares                     197,368                      $75,000
        08/08/2005                  Common Shares                     67,742                       $21,000
        08/08/2005                  Common Shares                     50,000                       $15,500
        01/09/2005                  Common Shares                     100,000                      $31,000
        16/09/2005                  Common Shares                     75,000                       $20,000
</TABLE>

Item 6     Exhibits and Reports on Form 8K

(a)        Exhibits

EXHIBIT
NUMBER          DESCRIPTION OF EXHIBIT
--------        ----------------------

3.1               Articles of Incorporation (1)

3.2               By-Laws (2)

31.1              Certification  of Chief  Executive  Officer  pursuant  to Rule
                  13a-14(a)  and  Rule  15d-14(a),   promulgated   under  C  the
                  Securities Exchange Act of 1934, as amended.

31.2              Certification  of Chief  Financial  Officer  pursuant  to Rule
                  13a-14(a)  and  Rule  15d-14(a),   promulgated   under  C  the
                  Securities Exchange Act of 1934, as amended.

32.1              Certification of Chief Executive Officer pursuant to 18 U.S.C.
                  Section  1350,  as adopted  pursuant  to C Section  906 of the
                  Sarbanes-Oxley Act of 2002.

32.2              Certification of Chief Financial Officer pursuant to 18 U.S.C.
                  Section  1350,  as adopted  pursuant  to C Section  906 of the
                  Sarbanes-Oxley Act of 2002.

                                       17
<PAGE>


(1)   Denotes  previously  filed  exhibits:  filed on  January 7, 2000 with 3045
      Corporation's Form SB-2 registration statement, file # 333-94265.

(2)   Denotes  previously  filed  exhibits:  filed on May 30,  2003  with  Liska
      Biometry, Inc.'s Form 10-KSB for the period ended December 31, 2001.

We hereby incorporate the following additional  documents by reference:  (a) our
Form  10-KSB for the year ended  December  31, 2004 which was filed on April 21,
2005,  December 31, 2003,  which was filed on April 7, 2004, for the year, ended
December 31, 2002,  which was filed on July 28,  2003;  and for the year,  ended
December  31,  2001  which  was  filed  on May 30,  2003;  (b) our  Registration
Statement on Form SB-2 and all amendments  thereto which was filed on January 7,
2000 and amended on February 8, 2000,  March 1, 2000,  March 14, 2000,  April 3,
2000,  and April 4, 2000;  (c) our Forms  10-QSB for the periods  ended June 30,
2005 which was filed on August 16,  2005,  March 31, 2005 which was filed on May
15, 2005; September 30, 2004 which was filed on November 15, 2004; June 30, 2004
which was filed on August 16,  2004;  March 31,  2004 which was filed on May 19,
2004;  September  30, 2003 which was filed on November 14,  2003;  June 30, 2003
which was filed on August 15, 2003; March 31, 2003 which was filed on August 15,
2003;  September 30, 2002 which was filed on July 28, 2003;  June 30, 2002 which
was filed on May 30, 2003;  March 31, 2002 which was filed on May 30, 2002; June
30, 2001 which was filed on April 4, 2002; September 30, 2001 which was filed on
April 4, 2002;  March 31, 2001 which was filed on May 21, 2001;  August 31, 2000
which was filed on September 15, 2000;  May 31, 2000 which was filed on June 20,
2000; and February 29, 2000 which was filed on April 14, 2000.

SIGNATURES

      Pursuant to the  requirements of Section 12 of the Securities and Exchange
Act of 1934,  the  Registrant  has duly  caused  this report to be signed on its
behalf by the undersigned, thereunto duly authorized.

                                                  LISKA BIOMETRY, INC.

                                                  Dated: November 11, 2005

                                                  By: /s/ Christopher J. LeClerc
                                                  ------------------------------
                                                  Christopher J. LeClerc
                                                  President and CEO
                                                  (Principal Executive Officer)

                                                  By: /s/ Manoj Hippola
                                                  ------------------------------
                                                  Manoj Hippola
                                                  Chief Financial Officer
                                                  (Principal Accounting Officer)

                                       18